Spencer Schwellenbach struck out 11 in 6 1/3 innings on his 25th birthday to help the Atlanta Braves beat the Boston Red Sox ...

A Friday panel discussion laid out some reasons for optimism about the future of innovation in our state, and also some ...

I n her State of the City address in March, Mayor Michelle Wu spoke about her then-2-month-old daughter. The world she ...

Edwards Lifesciences is projected to deliver steady profit and revenue growth through 2026. Click here to read more on EW ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Her wealth surpasses that of well-known entrepreneurs like Kiran Mazumdar-Shaw of Biocon and Falguni Nayar of Nykaa. In 2023, ...

Robinson, who was head of Skadden's Boston office, has joined the firm alongside fellow partners Laura Knoll and Chadé ...

Healthpeak’s development projects across its life science portfolio should be completed at development yields above the company's weighted average cost of capital and could drive strong internal ...

ZURICH, SWITZERLAND, May 29, 2025 -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp.

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

Servier today announced that the company was ranked among the top companies across several categories in PatientView's 2024 Corporate Reputation of Pharma in the U.S. survey. This annual ...